This study found that genetically predicted levels of Eotaxin, IL-2, RANTES, MIF, and TRAIL were positively correlated with the risk of NAFLD, while CTACK and IL-16 were negatively correlated. The gene discussed is CCL5; the disease is metabolic dysfunction-associated steatotic liver disease.